| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel And Secretary
1 company
Kasinger James R. serves as a General Counsel And Secretary at CRSP. Across recent SEC filings that breaks down to 0 buys and 22 sells. Those positions are worth an estimated $4.7M at current prices.
Historically, Kasinger James R.'s trades have earned a middling insider score of 60/100 across 13 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of +3.0%.
The biggest single holding is CRSP (~$4.7M) as General Counsel And Secretary. The recent filings there lean toward selling, a net 79,192 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 1,040 | $49.26 | $51,230.40 | -1.1% | - | - | |
| Oct 6, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 1,990 | $60.04 | $119,481.19 | -2.1% | - | - | |
| Sep 22, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 10,400 | $60.24 | $626,459.60 | -9.9% | - | - | |
| Mar 23, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,182 | $46.78 | $148,853.96 | -3.3% | +15.4% | - | |
| Mar 16, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,450 | $48.26 | $166,497.00 | -3.6% | +2.9% | - | |
| Mar 11, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 2,800 | $52.80 | $147,840.00 | -3.1% | +3.1% | - | |
| Feb 19, 2026 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 2,112 | $52.58 | $111,048.96 | -2.4% | - | - | |
| Oct 14, 2025 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 1,076 | $66.60 | $71,661.60 | -1.3% | -20.3% | - | |
| Mar 21, 2025 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,185 | $41.23 | $131,317.55 | -3.8% | +7.4% | +12.2% | |
| Mar 12, 2025 | CRSP Crispr Therapeutics AG | General Counsel And Secretary | Sale+OE | 3,966 | $42.67 | $169,242.12 | -4.8% | -1.3% | +12.4% |